KYVTHREE

Welcome to the Brand page for “KYVTHREE”, which is offered here for Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease;.

Its status is currently believed to be active. Its class is unavailable. “KYVTHREE” is believed to be currently owned by “Kyverna Therapeutics, Inc.”


Owner:
KYVERNA THERAPEUTICS, INC.
Owner Details
Description:
Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease;
Categories: THERAPEUTIC PHARMACEUTICAL TREATMENT